The IZAR Study for Psoriatic Arthritis
The IZAR Study for Psoriatic Arthritis - Now Enrolling
Psoriatic arthritis (PsA) is a painful condition that can affect both the joints and the skin.
PsA is not caused by overuse or aging, but by an overactive immune system, and it can affect people at any age.
Common symptoms of PsA include:
✔ Pain or swelling in one or more joints
✔ Joints that are stiff, red, or warm to the touch
✔ Swollen fingers or toes with a sausage-like appearance
✔ Patches of red, scaly skin (psoriasis)
If you struggle with psoriatic arthritis, you may qualify for the IZAR Clinical Study, now enrolling at select medical centers.
The IZAR Study is evaluating an investigational injectable medication designed to help relieve PsA symptoms.
If you qualify and choose to participate, you will receive study-related care and medical monitoring at no cost.
You may also be compensated for your time and travel to attend study visits at your local research center.
Why Participate?
If you were diagnosed with psoriatic arthritis at least 6 months ago, you may qualify for the IZAR Study. The study is for an inJectable investigational medication that is designed to help alleviate symptoms of psoriatic arthritis. If you qualify and choose to join the IZAR study, you will receive:
-
II' Regular assessment of your PsA condition by a medical specialist
-
II' Study-related care and study medication at no cost
-
II' Compensation for time and travel to attend study visits
-
II' The opportunity to help advance psoriatic arthritis research to potentially benefit others suffering from PsA
